Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Gross Profit 2016–2025
Ultragenyx Pharmaceutical Inc. annual/quarterly gross profit history and growth rate from 2017 to 2019. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Ultragenyx Pharmaceutical Inc. gross profit for the quarter ending June 30, 2019 was 23.4 M, a 84.80% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. gross profit for the twelve months ending June 30, 2019 was 65.2 M.
- Ultragenyx Pharmaceutical Inc. annual gross profit for 2018 was 50.3 M, a 1828.34% increase from 2017.
- Ultragenyx Pharmaceutical Inc. annual gross profit for 2017 was 2.6 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ultragenyx Pharmaceutical Inc. Gross Profit — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) gross profit over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's gross profit history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s gross profit by year and by quarter, including the growth rate.